Goodwin
Matthew Wetzel
- Deals
- 4
- Latest
- Apr 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 4 deals
Often works with
- Daniel Karelitz 4 deals together
- Timothy Holahan 3 deals together
- Andrea Akinbola 3 deals together
- Katerina Stavrianidis 3 deals together
- Arman Oruc 3 deals together
- Malhar Naik 2 deals together
- Gozde Guckaya 2 deals together
- Julie Tibbets 2 deals together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Apr 2026 | Obsidian Therapeutics | – | – | Placement | Legal adviser to Obsidian Therapeutics | Completed | 350.0 | Biotech+2 | Obsidian Therapeutics placement |
| Apr 2026 | Obsidian Therapeutics | – | Galera Therapeutics | Merger | Legal adviser to Obsidian Therapeutics | Completed | 413.5 | Biotech+2 | Galera Therapeutics and Obsidian Therapeutics merger |
| Mar 2026 | Ouro Medicines | – | Gilead | Acquisition | Legal adviser to Ouro Medicines (target) | Announced | 1,675.0 | Biotech+1 | Gilead acquisition of Ouro Medicines |
| Feb 2026 | Laysan Bio | – | Gannet BioChem | Acquisition | Legal adviser to Gannet BioChem (acquirer) | Announced | – | Pharma Services+2 | Gannet BioChem acquisition of Laysan Bio |
Deals where Matthew Wetzel is named on the firm's deal team, by the firm or the press.